The major factors that are responsible for the growth of the global mononucleosis diagnostics market include the rising health awareness and knowledge among patients, technological advancements leading to faster diagnosis, and the rise in the adolescent population. These factors are expected to further contribute to the growth of the market in the forecast period.
Mononucleosis is an infectious disease caused due to the Epstein-Barr virus (EBV), with infection typically occuring in teenagers. This virus can spread through the saliva. If anyone gets EBV, they may probably become immune to mononucleosis for the rest of their life. The rising awareness and knowledge about mononucleosis are driving the growth of the market. The virus that causes mononucleosis plays a role in the development of various types of head and neck cancer, thereby leading to awareness among the general population. Furthermore, there is an increase in the adolescent population across the world, particularly in Southeast Asia, which is expected to drive the overall growth of the market. As mononucleosis occurs in younger people, the large patient pool is expected to create tremendous opportunities for the market. According to the estimates of the United States Census Bureau, in 2017, there were 41,910,114 people aged between 10-19 in the United States, which is approximately 13% of the total population. In addition, according to the data published by the United Nations Population Fund (UNPF), an estimated 60% of the population in Sub-Saharan Africa is below the age of 25.
Key Market Trends
Monospot Test Segment by Test Type is Expected to Hold the Largest Market Share during the Forecast Period
A monospot test, also known as a heterophile antibody test, is a rapid test for the detection of infectious mononucleosis caused due to Epstein–Barr virus (EBV). This test is expected to hold the largest market share, owing to the benefits associated with the test, such as non-interference with other tests, accurate results, rapid detection of antibodies, and cost-effectiveness. The monospot test can be used in the detection of other diseases with similar symptoms, such as HIV, cytomegalovirus infection, and strep throat. Serological tests are the most common types of tests performed by the doctors to assign stage-specific treatments to patients. The major market players are focusing on the development of advanced products, which is expected to boost the market growth. Furthermore, the rising disease prevalence and the increase in awareness and knowledge regarding the disease are expected to drive the growth of this segment over the forecast period.
Asia-Pacific Accounted for the Highest Growth Rate in the Global Market
The Asia-Pacific region holds the highest growth rate for the mononucleosis diagnostic market, and it is expected to show a similar trend over the forecast period, without significant fluctuations. The rising adolescent population in the region is one of the major factors that is expected to drive the growth of the market over the forecast period. As per the estimates of UNICEF, in 2017, more than half of all adolescents across the world live in Asia, while South Asia is home to the largest number of adolescents in any region in the world (around 340 million ). South Asia is followed by East Asia and the Pacific, with around 277 million. Thus, owing to the number of adolescents, the region is expected to hold tremendous market opportunities over the forecast period.
The global mononucleosis diagnostics market is dominated by both major and small players. However, there are only a few small market players present in the niche segment of the market. The major market players are focusing on the development of advanced products in order to achieve faster detection.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support